リキッドバイオプシーには、血液サンプルを評価して、血液サンプル内を循環している腫瘍由来のがん細胞があるかどうか、または腫瘍細胞由来のDNA断片があるかどうかを確認することが含まれます。リキッドバイオプシーはがんの早期診断に役立つ可能性があります。
がんの罹患率の増加と、迅速で侵襲性の低い診断検査への関心の高まりにより、最近ではリキッドバイオプシーが推進されています。リキッドバイオプシー検査では、腫瘍細胞から採取した DNA または血液サンプルを使用して、血流中のがん細胞を検出します。政府はがんの早期発見を促進するためにさまざまな取り組みを行っています。世界のリキッドバイオプシー市場は、2023 年に 18 億 6,000 万ドルに達し、予測期間中に 20.56% の CAGR で成長すると予想されます。
目次
Table of contents
1. Executive Summary
2. Introduction
2.1 Liquid Biopsy: An Overview
2.1.1 Definition of Liquid Biopsy
2.1.2 Application of Liquid Biopsy
2.2 Liquid Biopsy Segmentation: An Overview
2.2.1 Liquid Biopsy Segmentation
2.2.2 Cancer Liquid Biopsy Segmentation
3. Global Market Analysis
3.1 Global Liquid Biopsy Market: An Analysis
3.1.1 Global Liquid Biopsy Market: An Overview
3.1.2 Global Liquid Biopsy Market by Value
3.1.3 Global Liquid Biopsy Market by Product & Service (Kits & Reagents, Platforms & Instruments and Services)
3.1.4 Global Liquid Biopsy Market by Circulating Biomarker (Circulating Tumor Cell, CT-DNA, Extracellular Vesicles, and Others)
3.1.5 Global Liquid Biopsy Market by End-User (Hospitals & Laboratories, and Government & Academic Research Centers)
3.1.6 Global Liquid Biopsy Market by Application (Cancer, and Non-Cancer)
3.1.7 Global Liquid Biopsy Market by Region (North America, Europe, Asia Pacific, and Rest of the world)
3.2 Global Liquid Biopsy Market: Product & Service Analysis
3.2.1 Global Liquid Biopsy Market by Product & Service: An Overview
3.2.2 Global Kits & Reagents Liquid Biopsy Market by Value
3.2.3 Global Platforms & Instruments Liquid Biopsy Market by Value
3.2.4 Global Services Liquid Biopsy Market by Value
3.3 Global Liquid Biopsy Market: Circulating Biomarker Analysis
3.3.1 Global Liquid Biopsy Market by Circulating Biomarker: An Overview
3.3.2 Global Circulating Tumor Cell Liquid Biopsy Market by Value
3.3.3 Global CT-DNA Liquid Biopsy Market by Value
3.3.4 Global Extracellular Vesicles Liquid Biopsy Market by Value
3.3.5 Global Others Liquid Biopsy Market by Value
3.4 Global Liquid Biopsy Market: End User Analysis
3.4.1 Global Liquid Biopsy Market by End User: An Overview
3.4.2 Global Hospitals & Laboratories Liquid Biopsy Market by Value
3.4.3 Global Government & Academic Research Centers Liquid Biopsy Market by Value
3.5 Global Liquid Biopsy Market: Application Analysis
3.5.1 Global Liquid Biopsy Market by Application: An Overview
3.5.2 Global Cancer Liquid Biopsy Market by Value
3.5.3 Global Cancer Liquid Biopsy Market by Cancer Type
3.5.4 Global Cancer Liquid Biopsy Segment Market by Value
3.5.5 Global Non-Cancer Liquid Biopsy Market by Value
4. Regional Market Analysis
4.1 North America Liquid Biopsy Market: An Analysis
4.1.1 North America Liquid Biopsy Market: An Overview
4.1.2 North America Liquid Biopsy Market by Value
4.1.3 North America Liquid Biopsy Market by Region (the US, Canada, and Mexico)
4.1.4 The US Liquid Biopsy Market by Value
4.1.5 Canada Liquid Biopsy Market by Value
4.1.6 Mexico Liquid Biopsy Market by Value
4.2 Europe Liquid Biopsy Market: An Analysis
4.2.1 Europe Liquid Biopsy Market: An Overview
4.2.2 Europe Liquid Biopsy Market by Value
4.2.3 Europe Liquid Biopsy Market by Region (Germany, France, UK, and Rest of Europe)
4.2.4 Germany Liquid Biopsy Market by Value
4.2.5 France Liquid Biopsy Market by Value
4.2.6 UK Liquid Biopsy Market by Value
4.2.7 Rest of Europe Liquid Biopsy Market by Value
4.3 Asia Pacific Liquid Biopsy Market: An Analysis
4.3.1 Asia Pacific Liquid Biopsy Market: An Overview
4.3.2 Asia Pacific Liquid Biopsy Market by Value
4.3.3 Asia Pacific Liquid Biopsy Market by Region (Japan, China, India, South Korea, and Rest of the Asia Pacific)
4.3.4 Japan Liquid Biopsy Market by Value
4.3.5 China Liquid Biopsy Market by Value
4.3.6 India Liquid Biopsy Market by Value
4.3.7 South Korea Liquid Biopsy Market by Value
4.3.8 Rest of Asia Pacific Liquid Biopsy Market by Value
4.4 Rest of the World Liquid Biopsy Market: An Analysis
4.4.1 Rest of the World Liquid Biopsy Market: An Overview
4.4.2 Rest of the World Liquid Biopsy Market by Value
5. Impact of COVID
5.1 Impact of COVID-19 on Global Liquid Biopsy Market
5.2 post-COVID-19 Impact on Global Liquid Biopsy Market
6. Market Dynamics
6.1 Growth Driver
6.1.1 Rising Healthcare Expenditure
6.1.2 Increasing in Global Urbanization
6.1.3 Surging Incidence of Cancer Cases
6.1.4 Growth In Demand For Precision Medicines
6.1.5 Myriad of Applications
6.2 Challenges
6.2.1 Need For More Clinical Trials
6.2.2 Standardized Pre-analytical Protocol And Assay Development And Regulatory Concerns
6.3 Market Trends
6.3.1 Involvement of Artificial Intelligence
6.3.2 Integration of Photonic Technology
6.3.3 New In Vitro Fertilization Technique For Embryos Testing
7. Competitive Landscape
7.1 Global Liquid Biopsy Market Players: Product Comparison
7.2 Global Liquid Biopsy Market Players: Product Trail Comparison
8. Company Profiles
8.1 Guardant Health
8.1.1 Business Overview
8.1.2 Business Strategy
8.2 Angle PLC
8.2.1 Business Overview
8.2.2 Revenue by Product & Service
8.2.3 Business Strategy
8.3 Qiagen N.V.
8.3.1 Business Overview
8.3.2 Revenue by Product Category
8.3.2 Business Strategy
8.4 Thermo Fisher Scientific Inc.
8.4.1 Business Overview
8.4.2 Operating Segment
8.4.3 Business Strategy
8.5 Bio-rad Laboratories, Inc.
8.5.1 Business Overview
8.5.2 Operating Segment
8.5.3 Business Strategy
8.6 Roche Holdings AG
8.6.1 Business Overview
8.6.2 Operating Segment
8.6.3 Business Strategy
8.7 Johnson & Johnson Ltd.
8.7.1 Business Overview
8.7.2 Operating Segment
8.7.3 Business Strategy
8.8 Illumina Inc.
8.8.1 Business Overview
8.8.2 Operating Segment
8.8.3 Business Strategy
8.9 MDxHealth SA
8.9.1 Business Overview
8.9.2 Operating Segment
8.9.3 Business Strategy
8.10 Myriad Genetics, Inc.
8.10.1 Business Overview
8.10.2 Business Strategy
8.11 Biocept Inc.
8.11.1 Business Overview
8.11.2 Business Strategy
8.12 Mesa Laboratories Inc.
8.12.1 Business Overview
8.12.2 Operating Segment
8.12.3 Business Strategy
8.13 Bio-Techne Corporation
8.13.1 Business Overview
8.13.2 Operating Segment
8.13.3 Business Strategy
Table of Figures
Figure 1: Application of Liquid Biopsy
Figure 2: Liquid Biopsy Segmentation
Figure 3: Cancer Liquid Biopsy Segmentation
Figure 4: Global Liquid Biopsy Market by Value; 2017-2021 (US$ Billion)
Figure 5: Global Liquid Biopsy Market by Value; 2022-2027 (US$ Billion)
Figure 6: Global Liquid Biopsy Market by Product & Service; 2021 (Percentage, %)
Figure 7: Global Liquid Biopsy Market by Circulating Biomarker; 2021 (Percentage, %)
Figure 8: Global Liquid Biopsy Market by End-User; 2021 (Percentage, %)
Figure 9: Global Liquid Biopsy Market by Application; 2021 (Percentage, %)
Figure 10: Global Liquid Biopsy Market by Region; 2021 (Percentage, %)
Figure 11: Global Kits & Reagents Liquid Biopsy Market by Value, 2017-2021 (US$ Million)
Figure 12: Global Kits & Reagents Liquid Biopsy Market by Value, 2022-2027 (US$ Billion)
Figure 13: Global Platforms & Instruments Liquid Biopsy Market by Value, 2017-2021 (US$ Million)
Figure 14: Global Platforms & Instruments Liquid Biopsy Market by Value, 2022-2027 (US$ Million)
Figure 15: Global Services Liquid Biopsy Market by Value, 2017-2021 (US$ Million)
Figure 16: Global Service Liquid Biopsy Market by Value, 2022-2027 (US$ Million)
Figure 17: Global Circulating Tumor Cell Liquid Biopsy Market by Value, 2017-2021 (US$ Million)
Figure 18: Global Circulating Tumor Cell Liquid Biopsy Market by Value, 2022-2027 (US$ Billion)
Figure 19: Global CT-DNA Liquid Biopsy Market by Value, 2017-2021 (US$ Million)
Figure 20: Global CT-DNA Liquid Biopsy Market by Value, 2022-2027 (US$ Million)
Figure 21: Global Extracellular Vesicles Liquid Biopsy Market by Value, 2017-2021 (US$ Million)
Figure 22: Global Extracellular Vesicles Liquid Biopsy Market by Value, 2022-2027 (US$ Million)
Figure 23: Global Others Liquid Biopsy Market by Value, 2017-2021 (US$ Million)
Figure 24: Global Others Liquid Biopsy Market by Value, 2022-2027 (US$ Million)
Figure 25: Global Hospitals & Laboratories Liquid Biopsy Market by Value, 2017-2021 (US$ Million)
Figure 26: Global Hospitals & Laboratories Liquid Biopsy Market by Value, 2022-2027 (US$ Billion)
Figure 27: Global Government & Academic Research Centers Liquid Biopsy Market by Value, 2017-2021 (US$ Million)
Figure 28: Global Government & Academic Research Centers Liquid Biopsy Market by Value, 2022-2027 (US$ Million)
Figure 29: Global Cancer Liquid Biopsy Market by Value, 2017-2021 (US$ Million)
Figure 30: Global Cancer Liquid Biopsy Market by Value, 2022-2027 (US$ Billion)
Figure 31: Global Cancer Liquid Biopsy Market by Cancer Type; 2021 (Percentage, %)
Figure 32: Global Cancer Liquid Biopsy Segment Market by Value, 2017-2021 (US$ Million)
Figure 33: Global Cancer Liquid Biopsy Segment Market by Value, 2022-2027 (US$ Billion)
Figure 34: Global Non-Cancer Liquid Biopsy Market by Value, 2017-2021 (US$ Million)
Figure 35: Global Non- Cancer Liquid Biopsy Market by Value, 2022-2027 (US$ Million)
Figure 36: North America Liquid Biopsy Market by Value; 2017-2021 (US$ Million)
Figure 37: North America Liquid Biopsy Market by Value; 2022-2027 (US$ Million)
Figure 38: North America Liquid Biopsy Market by Region; 2021 (Percentage, %)
Figure 39: The US Liquid Biopsy Market by Value, 2017-2021 (US$ Million)
Figure 40: The US Liquid Biopsy Market by Value, 2022-2027 (US$ Million)
Figure 41: Canada Liquid Biopsy Market by Value, 2017-2021 (US$ Million)
Figure 42: Canada Liquid Biopsy Market by Value, 2022-2027 (US$ Million)
Figure 43: Mexico Liquid Biopsy Market by Value, 2017-2021 (US$ Million)
Figure 44: Mexico Liquid Biopsy Market by Value, 2022-2027 (US$ Million)
Figure 45: Europe Liquid Biopsy Market by Value; 2017-2021 (US$ Million)
Figure 46: Europe Liquid Biopsy Market by Value; 2022-2027 (US$ Million)
Figure 47: Europe Liquid Biopsy Market by Region; 2021 (Percentage, %)
Figure 48: Germany Liquid Biopsy Market by Value; 2017-2021 (US$ Million)
Figure 49: Germany Liquid Biopsy Market by Value; 2022-2027 (US$ Million)
Figure 50: France Liquid Biopsy Market by Value; 2017-2021 (US$ Million)
Figure 51: France Liquid Biopsy Market by Value; 2022-2027 (US$ Million)
Figure 52: UK Liquid Biopsy Market by Value; 2017-2021 (US$ Million)
Figure 53: UK Liquid Biopsy Market by Value; 2022-2027 (US$ Million)
Figure 54: Rest of Europe Liquid Biopsy Market by Value; 2017-2021 (US$ Million)
Figure 55: Rest of Europe Liquid Biopsy Market by Value; 2022-2027 (US$ Million)
Figure 56: Asia Pacific Liquid Biopsy Market by Value; 2017-2021 (US$ Million)
Figure 57: Asia Pacific Liquid Biopsy Market by Value; 2022-2027 (US$ Million)
Figure 58: Asia Pacific Liquid Biopsy Market by Region; 2021 (Percentage, %)
Figure 59: Japan Liquid Biopsy Market by Value; 2017-2021 (US$ Million)
Figure 60: Japan Liquid Biopsy Market by Value; 2022-2027 (US$ Million)
Figure 61: China Liquid Biopsy Market by Value; 2017-2021 (US$ Million)
Figure 62: China Liquid Biopsy Market by Value; 2022-2027 (US$ Million)
Figure 63: India Liquid Biopsy Market by Value; 2017-2021 (US$ Million)
Figure 64: India Liquid Biopsy Market by Value; 2022-2027 (US$ Million)
Figure 65: South Korea Liquid Biopsy Market by Value; 2017-2021 (US$ Million)
Figure 66: South Korea Liquid Biopsy Market by Value; 2022-2027 (US$ Million)
Figure 67: Rest of Asia Pacific Liquid Biopsy Market by Value; 2017-2021 (US$ Million)
Figure 68: Rest of Asia Pacific Liquid Biopsy Market by Value; 2022-2027 (US$ Million)
Figure 69: Rest of the World Liquid Biopsy Market by Value; 2017-2021 (US$ Million)
Figure 70: Rest of the World Liquid Biopsy Market by Value; 2022-2027 (US$ Million)
Figure 71: Global Health Spending Per Capita; 2017-2021 (US$ Million)
Figure 72: Global Urban Population; 2017-2021 (Percentage, %)
Figure 73: The US Estimated Number of New Cancer Cases; 2017-2022 (Million)
Figure 74: Global Artificial Intelligence (AI) Market Revenues; 2020-2023 (US$ Billion)
Figure 75: Angle PLC Revenue by Product & Service; 2021 (Percentage, %)
Figure 76: Qiagen N.V. Revenue by Product Category; 2021 (Percentage, %)
Figure 77: Thermo Fisher Scientific Inc. Revenues by Segment; 2021 (Percentage, %)
Figure 78: Bio-rad Laboratories, Inc. Net Sales by Segment; 2021 (Percentage, %)
Figure 79: Roche Holdings AG Revenues by Operating Segment; 2021 (Percentage, %)
Figure 80: Johnson & Johnson Ltd. Sales by Segments; 2021 (Percentage, %)
Figure 81: Illumina Inc. Revenues by Segment; 2022 (Percentage, %)
Figure 82: MDxHealth SA Revenues by Segment; 2021 (Percentage, %)
Figure 83: Mesa Laboratories Inc. Revenues by Segment; 2022 (Percentage, %)
Figure 84: Bio-Techne Corporation Net Sales by Segment; 2022 (Percentage, %)
Table 1: Global Liquid Biopsy Market Players: Product Comparison
Table 2: Global Liquid Biopsy Market Players: Product Trail Comparison
